Company to Highlight New Data from Phase 2 REVERT IPF Clinical Trial of TTI-101 in Podium PresentationHOUSTON, Jan. 08, 2026 ...

Non-GAAP financial measures; see explanations and reconciliations that follow LANSING, Mich., January 08, 2026--(BUSINESS WIRE)--Neogen Corporation (NASDAQ: NEOG) announced today the results of the ...

Q2 2026 Earnings Call Transcript January 6, 2026 AAR Corp. beats earnings expectations. Reported EPS is $1.18, expectations ...

Several high-profile violent crimes in Myrtle Beach made headlines in 2025, sparking changes in policy and police presence.

Assays from final three Pepas infill holes show strong results, including:PEP072B - 47.60m @ 3.43g/t Au from surfacePEP073 - ...

Innovations in artificial intelligence, rising security threats, skilled labor pressure and the federal government’s rollback ...

AXT, Inc. will participate in the 28 th Annual Needham Growth Conference in New York City on Jan. 14 th, 2026. The company's presentation will take place at 3:00 p.m. ET. A webcast of the presentation ...

Once-weekly TransCon® CNP and TransCon® hGH combination therapy showed durable growth without compromising safety or ...

Aritzia Inc. ("Aritzia", the "Company", "we" or "our"), a design house with an innovative global platform offering Everyday ...

Multiple milestones anticipated from late-stage portfolio including topline results from DIAMOND Phase 3 trials with OCS-01 ...

You may unsubscribe at any time. By signing up, you agree to our terms of use and privacy policy. This site is protected by reCAPTCHA and the Google privacy policy and terms of service apply.